Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples.

IF 2.2 4区 医学 Q4 IMMUNOLOGY
Apmis Pub Date : 2024-10-25 DOI:10.1111/apm.13483
Jenni Horsma-Heikkinen, Anu Pätäri-Sampo, Tanja Holma, Annika Nevalainen, Nathalie Friberg, Hanna Jarva, Raisa Loginov, Jenni Antikainen
{"title":"Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples.","authors":"Jenni Horsma-Heikkinen, Anu Pätäri-Sampo, Tanja Holma, Annika Nevalainen, Nathalie Friberg, Hanna Jarva, Raisa Loginov, Jenni Antikainen","doi":"10.1111/apm.13483","DOIUrl":null,"url":null,"abstract":"<p><p>Accurate detection of Helicobacter pylori and its antimicrobial resistance is essential for eradication of the infections. The aim of this study was to compare five different CE-IVD marked assays in detection of H. pylori from 268 clinical stool samples. Samples were considered positive for H. pylori when at least three of the five tests were positive. Amplified IDEIA Hp StAR (Oxoid) and Premier Platinum HpSA PLUS (Meridian Bioscience Inc.) assays showed sensitivity of 100% [95% CI (confidence interval): 87-100] and LIAISON® Meridian H. pylori SA (DiaSorin) of 83.3% (95% CI: 66-93). Specificities of the assays were 94.5% (95% CI: 91-97), 95.4%; (95% CI: 92-97), and 97.1% (95% CI: 94-99) respectively. Amplidiag® H. pylori + ClariR (Mobidiag) assay showed 93.3% (95% CI: 78-99) and Allplex™ H. pylori & ClariR Assay (Seegene Inc.) 36.7% (95% CI: 22-55) sensitivity, while specificity of both was 97.9% (95% CI: 95-99). The Amplidiag® and Allplex™ assays concordantly detected clarithromycin resistance in positive for H. pylori samples. The Amplidiag® assay showed the highest accuracy, namely 97.4% (95% CI: 95-99). These data provide helpful information for planning laboratory diagnostics of H. pylori and detection of clarithromycin resistance from stool samples.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Apmis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apm.13483","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Accurate detection of Helicobacter pylori and its antimicrobial resistance is essential for eradication of the infections. The aim of this study was to compare five different CE-IVD marked assays in detection of H. pylori from 268 clinical stool samples. Samples were considered positive for H. pylori when at least three of the five tests were positive. Amplified IDEIA Hp StAR (Oxoid) and Premier Platinum HpSA PLUS (Meridian Bioscience Inc.) assays showed sensitivity of 100% [95% CI (confidence interval): 87-100] and LIAISON® Meridian H. pylori SA (DiaSorin) of 83.3% (95% CI: 66-93). Specificities of the assays were 94.5% (95% CI: 91-97), 95.4%; (95% CI: 92-97), and 97.1% (95% CI: 94-99) respectively. Amplidiag® H. pylori + ClariR (Mobidiag) assay showed 93.3% (95% CI: 78-99) and Allplex™ H. pylori & ClariR Assay (Seegene Inc.) 36.7% (95% CI: 22-55) sensitivity, while specificity of both was 97.9% (95% CI: 95-99). The Amplidiag® and Allplex™ assays concordantly detected clarithromycin resistance in positive for H. pylori samples. The Amplidiag® assay showed the highest accuracy, namely 97.4% (95% CI: 95-99). These data provide helpful information for planning laboratory diagnostics of H. pylori and detection of clarithromycin resistance from stool samples.

评估从粪便样本中诊断幽门螺旋杆菌的五种不同方法。
准确检测幽门螺杆菌及其抗菌药耐药性对于根除感染至关重要。本研究旨在比较五种不同的 CE-IVD 标记检测方法对 268 份临床粪便样本中幽门螺杆菌的检测结果。当五项检测中至少有三项呈阳性时,样本即被视为幽门螺杆菌阳性。Amplified IDEIA Hp StAR (Oxoid) 和 Premier Platinum HpSA PLUS (Meridian Bioscience Inc.) 检测法的灵敏度为 100% [95% CI(置信区间):87-100],LIAISON® Meridian H. pylori SA (DiaSorin) 检测法的灵敏度为 83.3%(95% CI:66-93)。检测的特异性分别为 94.5%(95% CI:91-97)、95.4%(95% CI:92-97)和 97.1%(95% CI:94-99)。Amplidiag® 幽门螺杆菌 + ClariR (Mobidiag) 检测法的灵敏度为 93.3% (95% CI: 78-99),Allplex™ 幽门螺杆菌和 ClariR 检测法 (Seegene Inc.) 的灵敏度为 36.7% (95% CI: 22-55),两者的特异性均为 97.9% (95% CI: 95-99)。Amplidiag® 和 Allplex™ 检测法能同时检测出幽门螺杆菌阳性样本对克拉霉素的耐药性。Amplidiag® 检测法的准确率最高,达到 97.4%(95% CI:95-99)。这些数据为制定幽门螺杆菌实验室诊断计划和从粪便样本中检测克拉霉素耐药性提供了有用的信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Apmis
Apmis 医学-病理学
CiteScore
5.20
自引率
0.00%
发文量
91
审稿时长
2 months
期刊介绍: APMIS, formerly Acta Pathologica, Microbiologica et Immunologica Scandinavica, has been published since 1924 by the Scandinavian Societies for Medical Microbiology and Pathology as a non-profit-making scientific journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信